16P11.2 Deletion and Duplication: Characterizing Neurologic Phenotypes in a Large Clinically Ascertained Cohort Kyle J
ORIGINAL ARTICLE 16p11.2 Deletion and Duplication: Characterizing Neurologic Phenotypes in a Large Clinically Ascertained Cohort Kyle J. Steinman,1* Sarah J. Spence,2 Melissa B. Ramocki,3 Monica B. Proud,4 Sudha K. Kessler,5 Elysa J. Marco,6 LeeAnne Green Snyder,7 Debra D’Angelo,8 Qixuan Chen,8 Wendy K. Chung,9 and Elliott H. Sherr,6 on behalf of the Simons VIP Consortium 1University of Washington and Seattle Children’s Research Institute, Seattle, Washington 2Boston Children’s Hospital, Harvard Medical School, Boston, Massachusetts 3University Otolaryngology, Providence, Rhode Island 4Baylor College of Medicine, Houston, Texas 5Children’s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania 6University of California, San Francisco, San Francisco, California 7Clinical Research Associates, New York, New York 8Mailman School of Public Health, Columbia University, New York, New York 9Columbia University Medical Center, New York, New York Manuscript Received: 12 August 2015; Manuscript Accepted: 13 June 2016 Chromosome 16p11.2 deletions and duplications are among the most frequent genetic etiologies of autism spectrum How to Cite this Article: disorder (ASD) and other neurodevelopmental disorders, Steinman KJ, Spence SJ, Ramocki MB, but detailed descriptions of their neurologic phenotypes Proud MB, Kessler SK, Marco EJ, Green have not yet been completed. We utilized standardized ex- Snyder LA, D’Angelo D, Chen Q, Chung amination and history methods to characterize a neurologic WK, Sherr EH, on behalf of the Simons phenotype in 136 carriers of 16p11.2 deletion and 110 carriers VIP Consortium. 2016. 16p11.2 Deletion of 16p11.2 duplication—the largest cohort to date of uni- and Duplication: Characterizing neurologic formly and comprehensively characterized individuals with phenotypes in a large clinically ascertained the same 16p copy number variants (CNVs).
[Show full text]